Zota Healthcare P/E Ratio
Zota Healthcare (ZOTA) P/E ratio is not applicable — EPS (TTM) ₹-22.46, 8 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 8 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 8
Current EPS: ₹-22.46
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -4.13 | -15 | Loss |
| Sept 2025 | -5.26 | -16 | Loss |
| Mar 2025 | -4.57 | -13 | Loss |
| Jun 2025 | -4.92 | -14 | Loss |
| Dec 2025 | -9.44 | -30 | Loss |
| Sept 2024 | -4.57 | -12 | Loss |
| Mar 2024 | -2.68 | -7 | Loss |
| Jun 2024 | -4.80 | -13 | Loss |
Healthcare Peers with Valid P/E Ratios — ZOTA Comparison
Healthcare sector average P/E 55.47, median 31.02 — ZOTA excluded (negative EPS).
Sector Average PE
55.47
Sector Median PE
31.02
Lowest PE
2.86
Profitable Companies
196
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.29 | ₹53 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.08 | ₹65 | Low |
| Shelter Pharma | SHELTER | 4.85 | ₹44 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| JFL Life Sciences | JFLLIFE | 6.44 | ₹86 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 7.11 | ₹51 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see ZOTA stock price BSE.
- Read ZOTA dividend payout details for the complete payout history and dividend yield track record.
- See ZOTA book value to compare market price against book value per share.